The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Economic Costs of Diabetes in the U.S. in 2012
Open accessAbstract
OBJECTIVE: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2012. RESEARCH DESIGN AND METHODS: The study uses a prevalence-based approach that combines the demographics of the U.S. population in 2012 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S. RESULTS: The total estimated cost of diagnosed diabetes in 2012 is $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity. The largest components of medical expenditures are hospital inpatient care (43% of the total medical cost), prescription medications to treat the complications of diabetes (18%), antidiabetic agents and diabetes supplies (12%), physician office visits (9%), and nursing/residential facility stays (8%). People with diagnosed diabetes incur average medical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, care for people with diagnosed diabetes accounts for more than 1 in 5 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. Indirect costs include increased absenteeism ($5 billion) and reduced productivity while at work ($20.8 billion) for the employed population, reduced productivity for those not in the labor force ($2.7 billion), inability to work as a result of disease-related disability ($21.6 billion), and lost productive capacity due to early mortality ($18.5 billion). CONCLUSIONS: The estimated total economic cost of diagnosed diabetes in 2012 is $245 billion, a 41% increase from our previous estimate of $174 billion (in 2007 dollars). This estimate highlights the substantial burden that diabetes imposes on society. Additional components of societal burden omitted from our study include intangibles from pain and suffering, resources from care provided by nonpaid caregivers, and the burden associated with undiagnosed diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Self-citationEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Self-citationBoyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,234
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Egede, L. E., Zheng, D., & Simpson, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.464 · Cited by 816
Impact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Deaths: preliminary data for 2011.
Hoyert, D. L., & Xu, J. (2012) · PubMed · Cited by 548
A review of adjusted estimators of attributable risk
Benichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440
Research works printed but not linked: 1
- Paris, 2001, Weighing in on type 2 diabetes in the military: characteristics of U.S. military personnel at entry who develop type 2 diabetes, Diabetes Care, 24, 1894, 10.2337/diacare.24.11.1894 · DOI
Cited by
Items 101–156 of 156
Schneider, A. L. C., Kalyani, R. R., Golden, S., Stearns, S. C., Wruck, L., Yeh, H. C., Coresh, J., & Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc15-1335 · Cited by 102
Lee, M.-R., Jung, S. M., Bang, H., Kim, H. S., & Kim, Y. B. (2018) · Medicine · doi:10.1097/md.0000000000010984 · Cited by 95
Buysman, E. K., Liu, F., Hammer, M., & Langer, J. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0199-z · Cited by 101
Fazel, M. T., Bagalagel, A., Lee, J. K., Martin, J. R., & Slack, M. K. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017711454 · Cited by 99
Effects of glucagon-like peptide-1 receptor agonists on renal function
Filippatos, T. D., & Elisaf, M. S. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i5.190 · Cited by 97
The value of mHealth for managing chronic conditions
Agnihothri, S., Cui, L., Delasay, M., & Rajan, B. (2020) · Health Care Management Science · doi:10.1007/s10729-018-9458-2 · Cited by 96
Bollyky, J. B., Bravata, D., Yang, J., Williamson, M., & Schneider, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3961730 · Cited by 85
Rodbard, H. W., Peters, A. L., Slee, A., Cao, A., Traina, S. B., & Alba, M. (2017) · Diabetes Care · doi:10.2337/dc16-1353 · Cited by 94
Hsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91
Bansal, V., Mottalib, A., Pawar, T. K., Abbasakoor, N., Chuang, E., Chaudhry, A., Sakr, M., Gabbay, R. A., & Hamdy, O. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000460 · Cited by 91
Professional fee ratios for US hospital discharge data.
Peterson, C., Xu, L., Florence, C., Grosse, S. D., & Annest, J. L. (2015) · Medical Care · doi:10.1097/mlr.0000000000000410 · Cited by 88
Runge, A. S., Kennedy, L., Brown, A. S., Dove, A. E., Levine, B. J., Koontz, S. P., Iyengar, V. S., Odeh, S. A., Close, K. L., Hirsch, I. B., et al. (2018) · Clinical Diabetes · doi:10.2337/cd17-0094 · Cited by 87
Miller-Archie, S. A., Jordan, H. T., Ruff, R. R., Chamany, S., Cone, J. E., Brackbill, R. M., Kong, J., Ortega, F., & Stellman, S. D. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.05.016 · Cited by 79
Al-Salameh, A., Chanson, P., Bucher, S., Ringa, V., & Becquemont, L. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.007 · Cited by 77
Monlezun, D. J., Kasprowicz, E., Tosh, K. W., Nix, J., Urday, P., Tice, D., Sarris, L., & Harlan, T. S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.007 · Cited by 76
Review of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
Razaz, J. M., Rahmani, J., Varkaneh, H. K., Thompson, J., Clark, C., & Abdulazeem, H. M. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.05.001 · Cited by 71
Impact of Diabetes on Stroke Risk and Outcomes: Two Nationwide Retrospective Cohort Studies
Liao, C.-C., Shih, C.-C., Yeh, C.-C., Chang, Y.-C., Hu, C.-J., Lin, J.-G., & Chen, T.-L. (2015) · Medicine · doi:10.1097/md.0000000000002282 · Cited by 66
Huo, L., Shaw, J. E., Wong, E., Harding, J. L., Peeters, A., & Magliano, D. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3948-x · Cited by 62
Pharmacological treatment of diabetes in older people
Valencia, W. M., & Florez, H. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12362 · Cited by 62
Hong, M., Lee, S. M., Park, S., Yoon, S.-J., Kim, Y.-E., & Oh, I.-H. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04255-y · Cited by 61
Wang, Y., Yang, S., Zhou, Q., Zhang, H., & Yi, B. (2019) · Kidney and Blood Pressure Research · doi:10.1159/000498838 · Cited by 60
Karnchanasorn, R., Huang, J., Ou, H.-Y., Feng, W., Chuang, L.-M., Chiu, K. C., & Samoa, R. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6195494 · Cited by 59
Griauzde, D., Kullgren, J. T., Liestenfeltz, B., Ansari, T., Johnson, E. H., Fedewa, A., Saslow, L. R., Richardson, C., & Heisler, M. (2019) · JMIR mHealth and uHealth · doi:10.2196/11267 · Cited by 58
Davydow, D. S., Zivin, K., Katon, W. J., Pontone, G. M., Chwastiak, L., Langa, K. M., & Iwashyna, T. J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2916-8 · Cited by 57
Vanstone, M., Rewegan, A., Brundisini, F., Giacomini, M., Kandasamy, S., & DeJean, D. (2017) · Chronic Illness · doi:10.1177/1742395316675024 · Cited by 48
Racial disparities in the screening and treatment of diabetic retinopathy
Coney, J. M., & Scott, A. W. (2022) · Journal of the National Medical Association · doi:10.1016/j.jnma.2021.12.011 · Cited by 53
Lauffenburger, J. C., Ghazinouri, R., Jan, S., Makanji, S., Ferro, C. A., Lewey, J., Wittbrodt, E., Lee, J., Haff, N., Fontanet, C. P., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214754 · Cited by 50
Marincic, P. Z., Salazar, M. V., Hardin, A., Scott, S., Fan, S. X., Gaillard, P. R., Wyatt, C., Watson, L., Green, P., Glover, P., et al. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.06.303 · Cited by 51
Effect of Obesogenic Medications on Weight‐Loss Outcomes in a Behavioral Weight‐Management Program
Desalermos, A., Russell, B., Leggett, C., Parnell, A., Ober, K., Hagerich, K., Gerlan, C., Ganji, G., Lee, E., Proudfoot, J. A., et al. (2019) · Obesity · doi:10.1002/oby.22444 · Cited by 47
A review of nutritional tracking mobile applications for diabetes patient use.
Darby, A., Strum, M. W., Holmes, E., & Gatwood, J. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0299 · Cited by 46
A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120382 · Cited by 57
Turner, R. M., Ma, Q., Lorig, K., Greenberg, J., & DeVries, A. R. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9225 · Cited by 39
Sierra, J. A., Shah, M., Gill, M. S., Flores, Z., Chawla, H., Kaufman, F. R., & Vigersky, R. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2017.1390474 · Cited by 38
Hepp, Z., Lage, M. J., Espaillat, R., & Gossain, V. V. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2018.1484749 · Cited by 37
Su, W., Chen, F., Dall, T. M., Iacobucci, W., & Perreault, L. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.150357 · Cited by 35
Gregory, N. S., Seley, J. J., Dargar, S. K., Galla, N., Gerber, L. M., & Lee, J. I. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1027-z · Cited by 33
Temporal occurrences and recurrence patterns of hypoglycemia during hospitalization
Ulmer, B. J., Kara, A., & Mariash, C. N. (2015) · Endocrine Practice · doi:10.4158/ep14355.or · Cited by 28
The Societal Value of Broader Access to Antiobesity Medications
Kabiri, M., Sexton Ward, A., Ramasamy, A., van Eijndhoven, E., Ganguly, R., Smolarz, B. G., Zvenyach, T., Goldman, D. P., & Baumgardner, J. R. (2020) · Obesity · doi:10.1002/oby.22696 · Cited by 26
Rodríguez-Sánchez, B., Angelini, V., Feenstra, T., & Alessie, R. J. M. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.09.011 · Cited by 26
Barbosa, A., Whiting, S., Ding, D., Brito, J., & Mendes, R. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckac074 · Cited by 23
Nesto, R., Fain, R., Li, Y., & Shanahan, W. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1178590 · Cited by 20
Qigong Exercises for the Management of Type 2 Diabetes Mellitus
Putiri, A., Close, J., Lilly, H., Guillaume, N., & Sun, G.-C. (2017) · Medicines · doi:10.3390/medicines4030059 · Cited by 19
Harvey, C., Koubek, R., Bégat, V., & Jacob, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816658058 · Cited by 19
Wilkinson, L., Hunt, B., Johansen, P., Iyer, N. N., Dang-Tan, T., & Pollock, R. F. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0402-8 · Cited by 18
Lee, T., Kuo, S., Yang, C., & Ou, H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14188 · Cited by 18
Evaluation of the timing and coordination of prandial insulin administration in the hospital
Alwan, D., Chipps, E., Yen, P.-Y., & Dungan, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.021 · Cited by 18
Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm
Tarasewicz, D., Karter, A. J., Pimentel, N., Moffet, H. H., Thai, K. K., Schlessinger, D., Sofrygin, O., & Melles, R. B. (2023) · Diabetes Care · doi:10.2337/dc22-1168 · Cited by 17
Bolge, S. C., Flores, N. M., & Phan, J. H. (2016) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000000874 · Cited by 14
Tsenkova, V. K., & Karlamangla, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164802 · Cited by 14
Radcliff, T. A., Côté, M. J., Whittington, M. D., Daniels, M. J., Bobroff, L. B., Janicke, D. M., & Perri, M. G. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.10.025 · Cited by 11
Feldman, D. I., Valero-Elizondo, J., Salami, J. A., Rana, J. S., Ogunmoroti, O., Osondu, C. U., Spatz, E. S., Virani, S. S., Blankstein, R., Blaha, M. J., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.004 · Cited by 11
Pronk, N. P. (2016) · Evidence Based Medicine · doi:10.1136/ebmed-2015-110292 · Cited by 10
Ritchie, N. D., Havranek, E. P., Moore, S. L., & Pereira, R. I. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.02.005 · Cited by 9
Pinkhasova, D., Swami, J. B., Patel, N., Karslioglu-French, E., Hlasnik, D. S., Delisi, K. J., Donihi, A. C., Rubin, D. J., Siminerio, L. S., Wang, L., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.03.013 · Cited by 9
Does type 1 diabetes affect male infertility: Type 1 diabetes exchange registry-based analysis
Raheem, O. A., Hehemann, M. C., Rogers, M. J., Fustok, J. N., Hirsch, I. B., & Walsh, T. J. (2021) · Société Internationale d’Urologie Journal · doi:10.48083/vvmv5977 · Cited by 3
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 36
- Issue
- 4
- Pages
- 1033-1046
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4229629337
- Cited by
- 2,163
- References
- 27
- FWCI
- 724.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.